← Back to Newsletter Archive

Greetings!

Welcome to the Monthly QPS Preclinical Newsletter


Know more about your compound before planning your next study. Explore how preclinical pharmacology and protein binding data can guide your decisions, and read the latest scientific insights from the QPS Blog.


Get a Clearer Picture of Protein Binding with QPS

Know how much of your candidate remains unbound before making key development decisions. QPS protein binding studies provide the data you need to inform dosing decisions and identify potential drug interactions, leading to more informed development plans.


All QPS protein binding studies are conducted in our DMPK laboratories in Newark, Delaware.

Discuss Your Protein Binding Study with QPS

Discover QPS Preclinical Pharmacology Services

Get preclinical pharmacology evidence shaped around your drug candidate and the development decisions ahead. QPS expert scientists can adapt existing in vivo models or develop new ones, supported by biochemical and histological analyses, to support your specific requirements.


Our Pharmacology, DMPK, and Toxicology teams work together to design research for your small molecule or biologic candidate.

Explore Pharmacology Services at QPS

Discover the Future of Science on the QPS Blog

A Growing Biosimilar Opportunity Meets a Limited Pipeline



As patents expire on biological drugs over the next decade, opportunities for biosimilar development should be growing. The pipeline tells a different story…


The FDA Seeks to Reduce Development Requirements

White Paper: Biosimilars Accelerated

Exploring the FDA’s Revised Pivotal Trial Guidance


Drug approval has long been associated with two identical pivotal clinical trials demonstrating that not only is the drug safe and effective, but also that the…


Looking Across the Development Program

Global Regulatory Affairs

Contact the Experts at QPS

 

Request a meeting with QPS preclinical, bioanalysis, translational medicine, and/or clinical research subject matter experts today to explore how we can help accelerate your next drug development program.

Visit our website www.qps.com 

or contact us at infopr@qps.com

to start your next study.

 
Linkedin  Youtube  X  Facebook

View as Webpage

www.qps.com | infopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive